Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: A cross-disorder proteomics analysis.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2019
Same author

Aligning the many definitions of treatment resistance in anxiety disorders: A systematic review.

Depression and anxiety·2019
Same author

Measuring social support in psychiatric patients and controls: Validation and reliability of the shortened Close Persons Questionnaire.

Journal of psychiatric research·2019
Same author

GWAS of Suicide Attempt in Psychiatric Disorders and Association With Major Depression Polygenic Risk Scores.

The American journal of psychiatry·2019
Same author

Accelerating research on biological aging and mental health: Current challenges and future directions.

Psychoneuroendocrinology·2019
Same author

A catalog of genetic loci associated with kidney function from analyses of a million individuals.

Nature genetics·2019

相关实验视频

Updated: Jul 10, 2026

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
14:01

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

14.5K

免疫代谢抑郁:从概念到实施

Brenda W J H Penninx1, Femke Lamers1, Rick Jansen1

  • 1Department of Psychiatry, Amsterdam Public Health and Amsterdam Neuroscience, Amsterdam UMC, Vrije University, Amsterdam, the Netherlands.

The Lancet regional health. Europe
|January 13, 2025
PubMed
概括
此摘要是机器生成的。

抑郁症的一个亚型,即免疫代谢性抑郁症,影响20-30%的患者,涉及炎症和代谢问题. 针对这些因素可能会改善这种特定抑郁症亚型的治疗结果.

关键词:
抑郁症 抑郁症 抑郁症脱脂血症是什么 脱脂血症是什么炎症 炎症是一种炎症.代谢变化 代谢变化神经生物学 神经生物学 神经生物学精准精神病学是一门精准的精神病学.

更多相关视频

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice
05:28

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice

Published on: May 15, 2019

22.0K
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
11:02

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

449

相关实验视频

Last Updated: Jul 10, 2026

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
14:01

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

14.5K
A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice
05:28

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice

Published on: May 15, 2019

22.0K
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
11:02

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

449

科学领域:

  • 神经科学是一个神经科学.
  • 精神病学是一个精神病学.
  • 免疫学 免疫学 免疫学
  • 代谢科学 代谢科学

背景情况:

  • 大型抑郁症 (MDD) 呈现出显著的异质性,使有效的治疗策略复杂化.
  • 了解抑郁症亚型的生物学基础对于开发个性化的干预措施至关重要.
  • 一个显著的抑郁症患者群体表现出免疫代谢失调.

研究的目的:

  • 审查免疫代谢抑郁的概念.
  • 为了突出这种抑郁症亚型的患病率和特征.
  • 讨论与精密精神病学一致的潜在治疗途径.

主要方法:

  • 文献综述侧重于抑郁症中的免疫代谢失调.
  • 分析特定抑郁症状,炎症标志物和代谢异常的聚类.
  • 检查免疫代谢抑郁症和心脏代谢疾病风险之间的关联.

主要成果:

  • 免疫代谢失调在20-30%的抑郁症患者中被发现.
  • 这种亚型的特征是不典型的抑郁症状 (高睡眠症,疲劳,高),低度系统性炎症和代谢异常 (肥胖,胰岛素抵抗).
  • 患有免疫代谢抑郁症的人面临心脏代谢疾病的风险增加,对标准抗抑郁药反应较差.

结论:

  • 免疫代谢性抑郁症代表了一种独特的MDD亚型,具有特定的生物标记.
  • 针对炎症,新陈代谢和生活方式因素的有针对性的干预措施对这个患者群体来说是有前途的.
  • 精准精神病学原则可以指导免疫代谢性抑郁症更有效的治疗选择.